Cited by 706Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

Intraneuronal Alzheimer Aβ42 Accumulates in Multivesicular Bodies and Is Associated with Synaptic Pathology

Open access
Takahashi, Reisuke H., Milner, Teresa A., Li, Feng, Nam, Ellen E., Edgar, Mark A., Yamaguchi, Haruyasu, Beal, M. Flint, Xu, Huaxi +2 more·2002·The American Journal of Pathology

Abstract

A central question in Alzheimer's disease concerns the mechanism by which beta-amyloid contributes to neuropathology, and in particular whether intracellular versus extracellular beta-amyloid plays a critical role. Alzheimer transgenic mouse studies demonstrate brain dysfunction, as beta-amyloid levels rise, months before the appearance of beta-amyloid plaques. We have now used immunoelectron microscopy to determine the subcellular site of neuronal beta-amyloid in normal and Alzheimer brains, and in brains from Alzheimer transgenic mice. We report that beta-amyloid 42 localized predominantly to multivesicular bodies of neurons in normal mouse, rat, and human brain. In transgenic mice and human Alzheimer brain, intraneuronal beta-amyloid 42 increased with aging and beta-amyloid 42 accumulated in multivesicular bodies within presynaptic and especially postsynaptic compartments. This accumulation was associated with abnormal synaptic morphology, before beta-amyloid plaque pathology, suggesting that intracellular accumulation of beta-amyloid plays a crucial role in Alzheimer's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0002-9440(10)64463-x

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL: Soluble pool of Abeta amyloid as a determi- nant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 1999, 46:860 -866
  2. Sisodia SS: Biomedicine: a cargo receptor mystery APParently solved? Science 2002, 295:805-807

Cited by

Sorted by citations

Authors
Takahashi, R. H., Milner, T. A., Li, F., Nam, E. E., Edgar, M. A., Yamaguchi, H., Beal, M. F., Xu, H., Greengard, P., & Gouras, G. K.
Affiliations
  • Cornell University (US)
  • Gunma University (JP)
  • Rockefeller University (US)
Corresponding author
Gouras, Gunnar K.
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2002-11
Volume
161
Issue
5
Pages
1869-1879
ISSN
0002-9440 (ISSN-L)
OpenAlex
W2030508474
Cited by
706
References
70
Citations by year
2026: 13 · 2025: 22 · 2024: 19 · 2023: 21 · 2022: 30 · 2021: 31 · 2020: 24 · 2019: 27 · 2018: 32 · 2017: 32 · 2016: 33 · 2015: 36 · 2014: 30 · 2013: 34 · 2012: 46
FWCI
14.99
Type
journal article
Language
en
Open access
Locations
  • American Journal Of Pathology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • Alzheimer's Association (NS02037, AG09464)
  • American Academy of Neurology
  • National Institutes of Health (2k08ns002037-04, HL18974)
  • National Institute on Aging (AG09464, P01AG009464)
  • National Heart, Lung, and Blood Institute (HL-18974, P01HL018974)
  • National Institute of Neurological Disorders and Stroke (NS02037)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, amyloid-beta 42, multivesicular bodies, synaptic pathology, postsynaptic compartment, subcellular localization, transgenic mouse model, aging, immunoelectron microscopy
MeSH terms
Aging, Alzheimer Disease, Animals, Brain, Humans, Mice, Transgenic, Middle Aged, Neurons, Peptide Fragments, Synapses, Amyloid beta-Peptides, Microscopy, Immunoelectron, Amyloid beta-Protein Precursor, Mice, Knockout, Cytoplasmic Vesicles, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review